HomeOCEA • NASDAQ
add
Ocean Biomedical Inc
Previous close
$0.63
Day range
$0.61 - $0.69
Year range
$0.46 - $7.79
Market cap
23.34M USD
Avg Volume
413.35K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 682.00K | -75.92% |
Net income | -17.23M | -50.77% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 4.00K | -99.66% |
Total assets | 1.85M | -14.35% |
Total liabilities | 94.59M | 48.22% |
Total equity | -92.74M | — |
Shares outstanding | 34.87M | — |
Price to book | -0.24 | — |
Return on assets | -71.09% | — |
Return on capital | 2.48% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2024info | Y/Y change |
|---|---|---|
Net income | -17.23M | -50.77% |
Cash from operations | -290.00K | 93.94% |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | -290.00K | -115.63% |
Free cash flow | -1.46M | -70.74% |
About
Ocean Biomedical is a new-generation American biopharmaceutical company based in Providence, Rhode Island. The company has product candidates addressing malaria, pulmonary fibrosis, and lung cancer. Ocean Biomedical was founded by Indian-American physician Chirinjeev Kathuria with Scientific Co-founders Jack Elias and Dr. Jonathan Kurtis, both from Brown University’s Medical School faculty. They aim to build a pipeline of preclinical, clinical, and commercial drug development by bringing together interdisciplinary expertise and resources. Wikipedia
Founded
2019
Headquarters
Website
Employees
7
